Private insurance companies say U.S. patients aren't paying the true cost of expensive medications such as Wegovy and Zepbound, which can easily cost upwards of $1,000. Wegovy, the weight-loss medication made by Novo Nordisk, is listed at $1,349 in the U.S. but sells for a fraction of that in Europe. In the United Kingdom, it costs $92, according to evidence provided…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Sec approves first 24-hour US exchange
Choosing a health insurance plan Choosing a health insurance plan
Advisor News
- CFP Board appoints K. Dane Snowden as CEO
- TIAA unveils ‘policy roadmap’ to boost retirement readiness
- 2026 may bring higher volatility, slower GDP growth, experts say
- Why affluent clients underuse advisor services and how to close the gap
- America’s ‘confidence recession’ in retirement
More Advisor NewsAnnuity News
- Insurer Offers First Fixed Indexed Annuity with Bitcoin
- Assured Guaranty Enters Annuity Reinsurance Market
- Ameritas: FINRA settlement precludes new lawsuit over annuity sales
- Guaranty Income Life Marks 100th Anniversary
- Delaware Life Insurance Company Launches Industry’s First Fixed Indexed Annuity with Bitcoin Exposure
More Annuity NewsHealth/Employee Benefits News
- CATHOLIC UNIVERSITY IN ILLINOIS STILL COVERS 'ABORTION CARE' WITH CAMPUS INSURANCE
- Major health insurer overspent health insurance funds
- OPINION: Lawmakers should extend state assistance for health care costs
- House Dems roll out affordability plan, take aim at Reynolds' priorities
- Municipal healthcare costs loom as officials look to fiscal 2027 budget
More Health/Employee Benefits NewsLife Insurance News